Evidence map›Paper›PMID 37705976›Full record

ArticleFrontiers in immunology2023

Identification of immunodominant T cell epitopes induced by natural Zika virus infection.

Christopher S Eickhoff, Krystal A Meza, Frances E Terry, Chase G Colbert, Azra Blazevic, Andres H Gutiérrez, E Taylor Stone, James D Brien, Amelia K Pinto, Hana M El Sahly and 9 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Future Goals and Long-term Vision of the Infectious Diseases Clinical Research Consortium/Vaccine and Treatment Evaluation Unit Network.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Christopher S EickhoffDepartment of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States.
Krystal A MezaDepartment of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States.
Frances E TerryEpiVax, Inc., Providence, RI, United States.
Chase G ColbertDepartment of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States.
Azra BlazevicDepartment of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States.
Andres H GutiérrezEpiVax, Inc., Providence, RI, United States.
E Taylor StoneDepartment of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, MO, United States.
James D BrienDepartment of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, MO, United States.
Amelia K PintoDepartment of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, MO, United States.
Hana M El SahlyDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States.
Mark J MulliganNew York University Grossman School of Medicine, Division of Infectious Diseases and Immunology, New York, NY, United States.
Nadine RouphaelEmory University School of Medicine, Division of Infectious Diseases, Department of Internal Medicine, Atlanta, GA, United States.
Maria L AlcaideUniversity of Miami, Division of Infectious Diseases, Miller School of Medicine, Miami, FL, United States.
Kay M TomashekDivision of Microbiology, Immunology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.
Chris FochtThe Emmes Company, LLC., Rockville, MD, United States.
William D MartinEpiVax, Inc., Providence, RI, United States.
Leonard MoiseEpiVax, Inc., Providence, RI, United States.
Anne S De GrootEpiVax, Inc., Providence, RI, United States.
Daniel F HoftDepartment of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States.

Funding

University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Savita Pahwa · 2007 to 2026
$33.8M
NIAID NIH HHS HHSN272201300015INIAID NIH HHS HHSN272201300018INIAID NIH HHS HHSN272201300021INIAID NIH HHS P30 AI073961
6 · The paper itself

Abstract

Zika virus (ZIKV) is a flavivirus primarily transmitted by

Indexed as

AedesZika VirusZika Virus InfectionAdultAnimalsEpitopes, T-LymphocyteFemaleGenes, MHC Class IHumansPregnancyEpitopes, T-LymphocyteEpiMatrixepitopesimmunodominanceimmunoinformaticsJanusMatrixT cellZika virus

Identifiers

PMID37705976
PMCPMC10497216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.